EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Probiotics for the prevention of ventilator-associated pneumonia and other outcomes in critically ill children: a systematic review and meta-analysis of randomized controlled trials

Surya Kant Tiwari iD, Priya Tripathi iD, Kaushik Mukhopadhyay, Vineet Kumar Kamal, Neetu Priya, Athar Javeth, Rakesh Lodha, Poonam Joshi iD

Journal of Tropical Pediatrics · 2026

DOI: 10.1093/tropej/fmag057 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Tropical Pediatrics, 2026. Verfasst von Surya Kant Tiwari und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, 229405, India. Hauptthemen laut MEDLINE: Probiotics, Pneumonia, Ventilator-Associated, Critical Illness. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critically ill children face high risks of mortality and healthcare-associated infections. Probiotics may improve outcomes by modulating gut microbiota and enhancing immune function. To evaluate the efficacy and safety of probiotics in critically ill children in pediatric intensive care units (PICUs). We systematically reviewed randomized controlled trials (RCTs) from PubMed, EMBASE, SCOPUS, and Web of Science until 10 June 2024. The primary outcome was all-cause mortality; secondary outcomes were ventilator-associated pneumonia (VAP), length of hospital stay (LOS), and duration of mechanical ventilation (MV). Risk ratios (RR) and mean differences (MD) were pooled using random-effects models (DerSimonian–Laird), with Hartung–Knapp adjustment as a sensitivity analysis. Evidence certainty was assessed using GRADE. Eight RCTs involving 744 children were included. Probiotics did not significantly reduce all-cause mortality (RR 0.85, 95% CI 0.66–1.11; P = .24; I² = 0%; low certainty); estimates were similar under Hartung–Knapp adjustment (RR 0.85, 0.69–1.06; P = .14) and in a sensitivity analysis restricted to low-risk-of-bias trials (RR 0.89, 0.60–1.34; P = .58). Probiotics significantly reduced VAP (RR 0.47, 95% CI 0.35–0.64; P < .0001; I² = 0%; high certainty), halving pneumonia risk (absolute risk reduction 21.9%; number needed to treat approximately 5). Reductions in LOS (MD −2.57 days, 95% CI −7.26 to 2.11; P = .20) and MV (MD −1.61 days, −4.43 to 1.20; P = .17) were nonsignificant (low certainty). No serious probiotic-associated adverse events occurred. High-certainty evidence indicates probiotics reduce VAP in critically ill children; the mortality effect was inconclusive. Probiotics may be considered an adjunctive strategy for VAP prevention in the PICU, pending larger multicenter trials. PROSPERO registry number CRD42024546238

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsPneumonia, Ventilator-AssociatedCritical IllnessHumansRandomized Controlled Trials as TopicIntensive Care Units, PediatricChildLength of StayRespiration, ArtificialTreatment OutcomeInfantChild, Preschool

Stichwörter der Autor:innen

Probioticschildcritical illnessintensive care unitsmeta-analysismortalitypneumoniaventilator-associated

Autor:innen und Institutionen

  • College of Nursing, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, 229405, India.
  • Career College of Nursing, Lucknow, Uttar Pradesh, 226013, India.
  • Department of Pharmacology, All India Institute of Medical Sciences, Kalyani, West Bengal, 741245, India.
  • Department of Biostatistics, All India Institute of Medical Sciences, Kalyani, West Bengal, 741245, India.
  • Dr. B.B. Dikshit Library, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • College of Nursing, All India Institute of Medical Sciences, Kalyani, West Bengal, 741245, India.

ORCID-Profile: Surya Kant Tiwari, Priya Tripathi, Poonam Joshi

Zitieren

APA

Tiwari, S. K., Tripathi, P., Mukhopadhyay, K., Kamal, V. K., Priya, N., Javeth, A., Lodha, R., & Joshi, P. (2026). Probiotics for the prevention of ventilator-associated pneumonia and other outcomes in critically ill children: a systematic review and meta-analysis of randomized controlled trials. Journal of Tropical Pediatrics. https://doi.org/10.1093/tropej/fmag057

Vancouver

Tiwari SK, Tripathi P, Mukhopadhyay K, Kamal VK, Priya N, Javeth A, et al. Probiotics for the prevention of ventilator-associated pneumonia and other outcomes in critically ill children: a systematic review and meta-analysis of randomized controlled trials. Journal of Tropical Pediatrics. 2026. doi:10.1093/tropej/fmag057

BibTeX
@article{Tiwari2026,
  author = {Tiwari, Surya Kant and Tripathi, Priya and Mukhopadhyay, Kaushik and Kamal, Vineet Kumar and Priya, Neetu and Javeth, Athar and Lodha, Rakesh and Joshi, Poonam},
  title = {Probiotics for the prevention of ventilator-associated pneumonia and other outcomes in critically ill children: a systematic review and meta-analysis of randomized controlled trials},
  journal = {Journal of Tropical Pediatrics},
  year = {2026},
  doi = {10.1093/tropej/fmag057}
}
Kostenlos starten →